Intracranial hemorrhage with Aptivu.
D004348:Drug Labeling; D017320:HIV Protease Inhibitors / Q000009:adverse effects*; D006801:Humans; D020300:Intracranial Hemorrhages / Q000139:chemically induced*; D011725:Pyridines / Q000009:adverse effects*; D011753:Pyrones / Q000009:adverse effects*; D019438:Ritonavir / Q000009:adverse effects*; D013449:Sulfonamides; D014481:United States; D014486:United States Food and Drug Administration
D017320:HIV Protease Inhibitors; D011725:Pyridines; D011753:Pyrones; D013449:Sulfonamides; D019438:Ritonavir; C107201:tipranavir